Title : Antiplatelet therapy in cardiovascular disease: Current status and future directions.

Pub. Date : 2022 Jun

PMID : 35001413






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In patients with acute cerebrovascular disease, aspirin combined with clopidogrel reduces subsequent risk, while in acute coronary syndrome, dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor (clopidogrel, prasugrel or ticagrelor) confers greater protection than aspirin monotherapy, with prasugrel and ticagrelor offering greater antiplatelet efficacy with faster onset of action than clopidogrel. Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens